Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-14 EDT 		5-day change 1st Jan Change
0.4037 USD +3.97% Intraday chart for Galmed Pharmaceuticals Ltd. -0.88% -11.27%
04-04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Galmed Pharmaceuticals Ltd., Q4 2021 Earnings Call, May 02, 2022
Transcript : Galmed Pharmaceuticals Ltd., Q3 2021 Earnings Call, Nov 08, 2021
Transcript : Galmed Pharmaceuticals Ltd., Q2 2021 Earnings Call, Aug 05, 2021
Transcript : Galmed Pharmaceuticals Ltd., Q1 2021 Earnings Call, May 13, 2021
Transcript : Galmed Pharmaceuticals Ltd., Q4 2020 Earnings Call, Mar 18, 2021
Transcript : Galmed Pharmaceuticals Ltd. - Special Call
Transcript : Galmed Pharmaceuticals Ltd., Q3 2020 Earnings Call, Nov 12, 2020
Transcript : Galmed Pharmaceuticals Ltd., Q2 2020 Earnings Call, Aug 06, 2020
Transcript : Galmed Pharmaceuticals Ltd., Q1 2020 Earnings Call, May 14, 2020
Transcript : Galmed Pharmaceuticals Ltd., Q4 2019 Earnings Call, Mar 12, 2020
Transcript : Galmed Pharmaceuticals Ltd., Q3 2019 Earnings Call, Nov 06, 2019
Transcript : Galmed Pharmaceuticals Ltd., Q2 2019 Earnings Call, Aug 05, 2019
Transcript : Galmed Pharmaceuticals Ltd., Q1 2019 Earnings Call, May 07, 2019
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. News Galmed Pharmaceuticals Ltd.
  5. Transcripts
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW